Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

LGVN vs IQV

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
LGVN
Longeveron Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$20M
5Y Perf.-98.9%
IQV
IQVIA Holdings Inc.

Medical - Diagnostics & Research

HealthcareNYSE • US
Market Cap$29.95B
5Y Perf.-8.5%

LGVN vs IQV — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
LGVN logoLGVN
IQV logoIQV
IndustryBiotechnologyMedical - Diagnostics & Research
Market Cap$20M$29.95B
Revenue (TTM)$1M$16.63B
Net Income (TTM)$-23M$1.39B
Gross Margin43.7%26.1%
Operating Margin-19.4%13.9%
Forward P/E13.9x
Total Debt$824K$16.17B
Cash & Equiv.$5M$1.98B

LGVN vs IQVLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

LGVN
IQV
StockFeb 21May 26Return
Longeveron Inc. (LGVN)1001.1-98.9%
IQVIA Holdings Inc. (IQV)10091.5-8.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: LGVN vs IQV

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: IQV leads in 4 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Longeveron Inc. is the stronger pick specifically for capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
LGVN
Longeveron Inc.
The Income Pick

LGVN is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • Dividend streak 1 yrs, beta 0.95
  • Lower volatility, beta 0.95, Low D/E 14.5%, current ratio 1.33x
  • Beta 0.95, current ratio 1.33x
Best for: income & stability and sleep-well-at-night
IQV
IQVIA Holdings Inc.
The Growth Play

IQV carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 5.9%, EPS growth 4.7%, 3Y rev CAGR 4.2%
  • 167.5% 10Y total return vs LGVN's -98.8%
  • 5.9% revenue growth vs LGVN's -49.9%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthIQV logoIQV5.9% revenue growth vs LGVN's -49.9%
Quality / MarginsIQV logoIQV8.3% margin vs LGVN's -18.9%
Stability / SafetyLGVN logoLGVNBeta 0.95 vs IQV's 1.33, lower leverage
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)IQV logoIQV+20.7% vs LGVN's -40.1%
Efficiency (ROA)IQV logoIQV4.7% ROA vs LGVN's -143.2%, ROIC 8.7% vs -5.9%

LGVN vs IQV — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

LGVNLongeveron Inc.

Segment breakdown not available.

IQVIQVIA Holdings Inc.
FY 2025
Research And Development Solutions
54.5%$8.9B
Technology And Analytics Solutions
40.6%$6.6B
Contract Sales And Medical Solutions
4.8%$788M

LGVN vs IQV — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLIQVLAGGINGLGVN

Income & Cash Flow (Last 12 Months)

IQV leads this category, winning 5 of 6 comparable metrics.

IQV is the larger business by revenue, generating $16.6B annually — 13871.6x LGVN's $1M. IQV is the more profitable business, keeping 8.3% of every revenue dollar as net income compared to LGVN's -18.9%. On growth, IQV holds the edge at +8.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricLGVN logoLGVNLongeveron Inc.IQV logoIQVIQVIA Holdings In…
RevenueTrailing 12 months$1M$16.6B
EBITDAEarnings before interest/tax-$22M$3.5B
Net IncomeAfter-tax profit-$23M$1.4B
Free Cash FlowCash after capex-$19M$2.7B
Gross MarginGross profit ÷ Revenue+43.7%+26.1%
Operating MarginEBIT ÷ Revenue-19.4%+13.9%
Net MarginNet income ÷ Revenue-18.9%+8.3%
FCF MarginFCF ÷ Revenue-15.9%+16.1%
Rev. Growth (YoY)Latest quarter vs prior year-39.5%+8.4%
EPS Growth (YoY)Latest quarter vs prior year+11.1%+15.0%
IQV leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

LGVN leads this category, winning 2 of 3 comparable metrics.
MetricLGVN logoLGVNLongeveron Inc.IQV logoIQVIQVIA Holdings In…
Market CapShares × price$20M$29.9B
Enterprise ValueMkt cap + debt − cash$17M$44.1B
Trailing P/EPrice ÷ TTM EPS-0.68x22.51x
Forward P/EPrice ÷ next-FY EPS est.13.89x
PEG RatioP/E ÷ EPS growth rate0.56x
EV / EBITDAEnterprise value multiple12.87x
Price / SalesMarket cap ÷ Revenue16.99x1.84x
Price / BookPrice ÷ Book value/share2.71x4.62x
Price / FCFMarket cap ÷ FCF14.60x
LGVN leads this category, winning 2 of 3 comparable metrics.

Profitability & Efficiency

IQV leads this category, winning 5 of 8 comparable metrics.

IQV delivers a 22.1% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $-200 for LGVN. LGVN carries lower financial leverage with a 0.15x debt-to-equity ratio, signaling a more conservative balance sheet compared to IQV's 2.44x. On the Piotroski fundamental quality scale (0–9), IQV scores 4/9 vs LGVN's 2/9, reflecting mixed financial health.

MetricLGVN logoLGVNLongeveron Inc.IQV logoIQVIQVIA Holdings In…
ROE (TTM)Return on equity-199.8%+22.1%
ROA (TTM)Return on assets-143.2%+4.7%
ROICReturn on invested capital-5.9%+8.7%
ROCEReturn on capital employed-159.8%+11.0%
Piotroski ScoreFundamental quality 0–924
Debt / EquityFinancial leverage0.15x2.44x
Net DebtTotal debt minus cash-$4M$14.2B
Cash & Equiv.Liquid assets$5M$2.0B
Total DebtShort + long-term debt$824,000$16.2B
Interest CoverageEBIT ÷ Interest expense3.10x
IQV leads this category, winning 5 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

IQV leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in IQV five years ago would be worth $7,632 today (with dividends reinvested), compared to $161 for LGVN. Over the past 12 months, IQV leads with a +20.7% total return vs LGVN's -40.1%. The 3-year compound annual growth rate (CAGR) favors IQV at -2.4% vs LGVN's -69.8% — a key indicator of consistent wealth creation.

MetricLGVN logoLGVNLongeveron Inc.IQV logoIQVIQVIA Holdings In…
YTD ReturnYear-to-date+47.4%-21.7%
1-Year ReturnPast 12 months-40.1%+20.7%
3-Year ReturnCumulative with dividends-97.2%-7.0%
5-Year ReturnCumulative with dividends-98.4%-23.7%
10-Year ReturnCumulative with dividends-98.8%+167.5%
CAGR (3Y)Annualised 3-year return-69.8%-2.4%
IQV leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — LGVN and IQV each lead in 1 of 2 comparable metrics.

LGVN is the less volatile stock with a 0.95 beta — it tends to amplify market swings less than IQV's 1.33 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IQV currently trades 71.4% from its 52-week high vs LGVN's 48.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricLGVN logoLGVNLongeveron Inc.IQV logoIQVIQVIA Holdings In…
Beta (5Y)Sensitivity to S&P 5000.95x1.33x
52-Week HighHighest price in past year$1.80$247.05
52-Week LowLowest price in past year$0.47$134.65
% of 52W HighCurrent price vs 52-week peak+48.6%+71.4%
RSI (14)Momentum oscillator 0–10038.458.4
Avg Volume (50D)Average daily shares traded6.8M1.6M
Evenly matched — LGVN and IQV each lead in 1 of 2 comparable metrics.

Analyst Outlook

IQV leads this category, winning 1 of 1 comparable metric.
MetricLGVN logoLGVNLongeveron Inc.IQV logoIQVIQVIA Holdings In…
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$225.63
# AnalystsCovering analysts44
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises12
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%+4.2%
IQV leads this category, winning 1 of 1 comparable metric.
Key Takeaway

IQV leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). LGVN leads in 1 (Valuation Metrics). 1 tied.

Best OverallIQVIA Holdings Inc. (IQV)Leads 4 of 6 categories
Loading custom metrics...

LGVN vs IQV: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is LGVN or IQV a better buy right now?

For growth investors, IQVIA Holdings Inc.

(IQV) is the stronger pick with 5. 9% revenue growth year-over-year, versus -49. 9% for Longeveron Inc. (LGVN). IQVIA Holdings Inc. (IQV) offers the better valuation at 22. 5x trailing P/E (13. 9x forward), making it the more compelling value choice. Analysts rate IQVIA Holdings Inc. (IQV) a "Buy" — based on 44 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — LGVN or IQV?

Over the past 5 years, IQVIA Holdings Inc.

(IQV) delivered a total return of -23. 7%, compared to -98. 4% for Longeveron Inc. (LGVN). Over 10 years, the gap is even starker: IQV returned +167. 5% versus LGVN's -98. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — LGVN or IQV?

By beta (market sensitivity over 5 years), Longeveron Inc.

(LGVN) is the lower-risk stock at 0. 95β versus IQVIA Holdings Inc. 's 1. 33β — meaning IQV is approximately 40% more volatile than LGVN relative to the S&P 500. On balance sheet safety, Longeveron Inc. (LGVN) carries a lower debt/equity ratio of 15% versus 2% for IQVIA Holdings Inc. — giving it more financial flexibility in a downturn.

04

Which is growing faster — LGVN or IQV?

By revenue growth (latest reported year), IQVIA Holdings Inc.

(IQV) is pulling ahead at 5. 9% versus -49. 9% for Longeveron Inc. (LGVN). On earnings-per-share growth, the picture is similar: IQVIA Holdings Inc. grew EPS 4. 7% year-over-year, compared to -20. 6% for Longeveron Inc.. Over a 3-year CAGR, IQV leads at 4. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — LGVN or IQV?

IQVIA Holdings Inc.

(IQV) is the more profitable company, earning 8. 3% net margin versus -1893. 6% for Longeveron Inc. — meaning it keeps 8. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IQV leads at 14. 0% versus -1942. 2% for LGVN. At the gross margin level — before operating expenses — LGVN leads at 67. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — LGVN or IQV?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is LGVN or IQV better for a retirement portfolio?

For long-horizon retirement investors, Longeveron Inc.

(LGVN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 95)). Both have compounded well over 10 years (LGVN: -98. 8%, IQV: +167. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between LGVN and IQV?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

LGVN

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 26%
Run This Screen
Stocks Like

IQV

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform LGVN and IQV on the metrics below

Revenue Growth>
%
(LGVN: -39.5% · IQV: 8.4%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.